Physician profile
Aimee E Light
NPI 1609123108
$4,937.98
in general payments reported to CMS, 2019-2025
16 companies · $3,714 in 2025
The $3,714 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.86 · 2022: $32.90 · 2023: $236 · 2024: $929 · 2025: $3,714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,402 · Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,401.71 |
| Food and Beverage | $1,476.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,613.49 | 2025 | Navitor |
| Boston Scientific Corporation | $1,338.17 | 2025 | Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $1,261.95 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $156.99 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $119.44 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $114.53 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.01 | 2021-2024 | Lifevest |
| Cvrx, INC. | $55.46 | 2024 | Barostim Neo System |
| Pfizer INC. | $40.67 | 2022-2023 | |
| Irhythm Technologies, INC. | $34.20 | 2024 | Zio Monitor, Zio Xt Patch |
| Daiichi Sankyo INC. | $27.13 | 2023 | Injectafer |
| Shockwave Medical, INC | $24.01 | 2025 | |
| Novo Nordisk INC | $19.84 | 2025 | Ozempic |
| Janssen Pharmaceuticals, INC | $19.83 | 2023 | Xarelto |
| Glaxosmithkline, LLC. | $13.71 | 2025 | Nucala |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $13.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.